We have previously demonstrated that equal doses of human insulin, insulin aspart and the two biphasic aspart preparations BIAsp50 and BIAsp70 have distinct pharmacokinetic and -dynamic properties in patients with T1D [11] and this finding prompted us to investigate their effect on the circulating IGF system, which is known to respond to insulin. Here, IGF1 is linked to type 1 diabetes mellitus.